Preoperative natural killer cell activity: Correlation with distant metastases in curatively research colorectal carcinomas

International Surgery

Volumn 82, Issue 2, 1997, Pages 190-193

  Koda, Keiji ^a   Saito, Norio ^a   Takiguchi, Nobuhiro ^a   Oda, Kenji ^a   Nunomura, Masao ^a   Nakajima, Nobuyuki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Colorectal carcinoma; Distant metastasis; Immunity; Natural killer (NK) cell activity; Perioperative host; Proportional hazards regression

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOLOGICAL PARAMETERS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NATURAL KILLER CELL; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY;

AGED; CD4-CD8 RATIO; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 0030878746     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:420-425.
2. Japanese Research Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. 5th edition. Tokyo: Kimbara, 1994.
3. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-481.
4. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
5. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187-202.
6. Vujanovic NL, Herberman RB, Maghazachi AA, Hiserodt JC. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large glandular lymphocyte and their rapid expansion and conversion into lymphokine-activated killer cells. J Exp Med 1988;167:15-29.
7. Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse. 1. Cytotoxic cells with specificity for mouse Monkey leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975;5:112-117.
8. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. 1. Distribution of reactivity and specificity. Int J Cancer 1975;16:216-229.
9. Aboud M, Kingsmore S, Segal S. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones. Nat Immun 1993;12:17-24.
10. Stern AS, Podlaski FJ, Hulmes JD, Pan Y-CE, Quinn PM, Wolitzky AG et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-6812.
11. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-845.
12. Balch CM, Tilden AB, Dougherty PA, Cloud GA, Abo T. Heterogeneity of natural killer lymphocytes abnormalities in colon cancer patients. Surgery 1984;95:63-70.
13. Tanaka N, Hashimoto T, Matsui T, Ohida J, Ono M, Orita K. Natural cytotoxic reactivity of peripheral blood lymphocytes from digestive tract cancer patients against a colon cancer cell line and virus-infected Hela cells. Jpn J Cancer Res 1983;74:419-425.
14. Steinhauer EH, Doyle AT, Reed J, Kadish AS. Defective natural cytotoxicity in patients with cancer: Normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol 1982;129:2255-2259.
15. Funa K, Nilsson B, Jacobsson G, Aim GV. Decreased natural killer cell activity and interferon production by leukocytes in patients with adenocarcinoma of the pancreas. Br J Cancer 1984;50:231-233.
16. Son K, Kew M, Rabson AR. Depressed natural killer cell activity in patients with hepatocellular carcinoma. In vitro effects of interferon and levamisole. Cancer 1982;50:2820-2825.
17. Rager-Zisman B, Aboud M, Gopas J, Har-Vardi I, Hammerling GJ, Segal S. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region. Semin Cancer Biol 1991;2:329-336.
18. Uchida A, Kariya Y, Inoue N, Okamoto N, Sugie K. Biological significance of autologous tumor killing. In: Goldfarb RH, Whiteside TL, editors. Tumor Immunology and Cancer Therapy. New York: Marcel Dekker, Inc, 1994:195-206.
19. Coulie P, Weynants P, Muller C, Lehmann F, Herman J, Baurain J-F et al. Gene coding for antigens recognized on human tumors by autologous cytotoxic T lymphocytes. Ann NY Acad Sci USA 1993; 690:113-119.
20. Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S et al. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 1993;53:3569-3573.
21. Kawakami Y, Eliyasu S, Jennings C, Sakaguchi K, Kang X, Southwood S et al. Recognition of multiple epitopes in the human melanoma antigen gp 100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 1995;154:3961-3968.